comparemela.com

Latest Breaking News On - ரோபர்ட்டா ஹாரிங்டன் - Page 1 : comparemela.com

Viruses are the most common cause of myocarditis in children, experts offer guidance

Viruses are the most common cause of myocarditis in children, experts offer guidance
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

CDC investigating rare myocarditis in teens, young adults; COVID-19 vaccine still advised for all who are eligible

COVID-19 vaccine benefits still outweigh risks, despite possible rare heart complications

Late last week, the U.S. Centers for Disease Control and Prevention (CDC) alerted health care professionals that they are monitoring the Vaccine Adverse Events Reporting System (VAERS) and the Vaccine Safety Datalink (VSD) for cases of young adults developing the rare heart-related complication myocarditis, after receiving a COVID-19 vaccine manufactured by Pfizer-BioNTech or Moderna.

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine Last Friday, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S. The temporary pause was due to reports of a serious condition called cerebral venous sinus thrombosis (CVST), which refers to blood clots in the brain s veins - not in the arteries, as is the case for most strokes - in combination with thrombocytopenia (low blood platelet count). CVST and thrombocytopenia together is called thrombosis-thrombocytopenia syndrome (TTS). When TTS is linked to receiving a COVID-19 vaccine, it is called vaccine-induced immune thrombotic thrombocytopenia (VITT). CVST has also been associated with cases of TTS in adults who received the AstraZeneca COVID-19 vaccine available in Europe, according to the European Medicines Agency, the agency responsible f

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.